Exponent : 2026 Investor Presentation

EXPO

Published on 04/30/2026 at 11:44 pm EDT

2026 Investor Presentation

@ 2026 Exponent, Inc. | Privileged & Confidential 1

Premium Engineering & Scientific Consulting

Exponent harnesses the power of technical excellence, objectivity and disciplinary diversity to solve our clients' toughest challenges

3

World's Best Problem Solvers for More

than Five Decades

OVERVIEW OUR WORLD CLASS TALENT

50+ years of expansion and diversification across disciplines and industries

Best-in-class engineering and scientific expertise

Bespoke multidisciplinary solutions for high

exposure, high-risk challenges around the world

Unparalleled reputation for rigorous,

objective technical analyses throughout the product lifecycle

900+

Consulting Staff

250+

Standards

committees and advisory boards served

650+

Doctoral-level

professionals

50+

Staff serving on

editorial review boards/peer reviewers

90+

Disciplines

1,250+

Staff academic

articles published

Note: Figures as of 12/31/25

4

Proven Track Record of Results

STRONG FINANCIAL POSITION

COMPELLING INVESTMENT THESIS

Positioned to capitalize on increasing demand for

a safer, healthier, more sustainable world

$582M

FY25 Revenue

28%

FY25 EBITDA Margin1,2

Wide competitive moat through unique multi-

disciplinary solutions and world class talent

Strategic resource management and agility to

capitalize on high growth areas

Strong profitable organic growth

$0.31

Quarterly Dividend

$2.07

FY25 EPS

Healthy balance sheet and strong cash flow

generation

1Refer to non-GAAP reconciliation on slide 25 2EBITDA Margin % = EBITDA/Revenues before Reimbursements

5

50+ Years of Future-Focused Thinking

Failure Analysis Associates (FaAA) was founded

Expansion: Test and Engineering Center

Acquired Environmental Health Strategies and PTI Environmental Services

Acquired Novigen Sciences

Project: Toyota unintended acceleration

Project: Camp Fire, California

Project: Cruise, Automated Vehicle Incident Response

1970 1980 1990 2000 2010 2020

Exponent adds new engineering and science disciplines

Public Filing/ NASDAQ listing under the ticker "FAIL"

Name changed to Exponent Inc.; NASDAQ listing updated to "EXPO"

Expanded presence into Asia

Project: Deep Water Horizon explosion, Gulf Coast

6

Connecting the Lessons of Past Failures

with Tomorrow's Solutions

We leverage our wealth of failure analysis learnings to develop the breakthrough insights our

clients need, generating opportunity at every stage of the product lifecycle.

Design

Prototype

Upgrades and Refinements

Product Lifecycle

Test

Production

Pre-Production

Reactive Services

Understanding the past

Litigation support

Accident and failure investigation

Product recalls

Regulatory actions

Insurance investigations

Proactive Services

Charting a course for the future across the product lifecycle

Product and process improvement

Research and development

Risk management

Regulatory consulting

7

Our History of Growth & Diversification

2025

1967

Reactive Proactive

8

Diversified Portfolio Provides Resilience

CONSUMER

PRODUCTS

ENERGY

TRANSPORTATION

CHEMICALS

LIFE SCIENCES & HEALTHCARE

CONSTRUCT

Reactive Proactive

Reactive work driven by disputes and failure analysis work across the globe which have historically

been less impacted by challenging economic cycles

Note: Revenue and mix reflect Full Year 2025 results

9

Diverse Customer Relationships

Our Clients

10K

FY25

Engagements

2K

FY25

Clients

Corporate

Legal Government

Deep Industry Know-How

Construction

Chemicals

Consumer Products

Electronics

Energy

Food

& Beverage

Government

Industrial

& Manufacturing

Life Sciences

& Healthcare

Mining

& Forestry

Software & Computer

Science

Transportation Utilities

10

Strong Growth Momentum Through Safety, Health & Environmental Trends

TRANSPORTATION UTILITIES

CONSUMER ELECTRONICS

LIFE SCIENCES

& HEALTHCARE

CHEMICAL

Key Drivers / Trends

Automation

Electrification

Energy transition

Climate resilience

Aging infrastructure

Augmented and virtual reality

Wearable technology

Digital health

Health equity

Combination products

Human health effects

Environmental impact

Selected Exponent Solutions

Advanced Driver Assistance System litigation

Battery performance and safety studies

Asset risk analysis

Climate vulnerability studies

Wildfire

investigations

AI/ML studies

Product development consulting

Medical device recalls

Real-world evidence strategy and solutions

Regulatory consulting

Toxic tort litigation

Product

stewardship

11

Our Bespoke Multidisciplinary Teams

Exponent's flexibility to build the right team at the right time

is truly unrivaled.

Polymers & Chemistry

Biomedical Engineering & Sciences Mechanical Engineering

Ecological & Biological Sciences

Thermal Sciences

Vehicle Engineering

Human Factors

Projects

Biomechanics

Electrical Engineering & Computer Science

Metallurgical & Corrosion Engineering

Data Sciences

12

Our Bespoke Multidisciplinary Teams

Exponent's flexibility to build the right team at the right time

is truly unrivaled.

Environmental & Earth Sciences

Polymers & Chemistry

Biomedical Engineering & Sciences

Chemical Regulation & Food Safety

Mechanical Engineering v

Thermal Sciences

Vehicle Engineering

Batteries

Civil & Structural Engineering

Construction Consulting

Human Factors

Biomechanics

Electrical Engineering & Computer Science

Metallurgical & Corrosion Engineering

Data Sciences

13

Our Bespoke Multidisciplinary Teams

Exponent's flexibility to build the right team at the right time

is truly unrivaled.

Polymers & Chemistry

Biomedical Engineering & Sciences

Mechanical Engineering

Thermal Sciences

Vehicle Engineering

Human Factors

PFAS

Civil & Structural Engineering

Construction Consulting

Biomechanics

Electrical Engineering & Computer Science

v

Materials Science & Electrochemistry

Metallurgical & Corrosion Engineering

Data Sciences

14

Our Bespoke Multidisciplinary Teams

Exponent's flexibility to build the right team at the right time

is truly unrivaled.

Biomedical Engineering & Sciences

v

Ecological & Biological Sciences

Mechanical Engineering

Chemical Regulation & Food Safety

Thermal Sciences

Health Sciences

ADAS

Vehicle Engineering

Civil & Structural Engineering

Human Factors

Construction Consulting

Biomechanics

v

Electrical Engineering & Computer Science

Metallurgical & Corrosion Engineering

Polymers & Chemistry

Materials Science & Electrochemistry

Data Sciences

Environmental & Earth Sciences

15

World-Class Culture & Talent

Sourcing candidates from increasingly diverse backgrounds and skill sets

Leveraging science, technology, engineering and math (STEM) to empower the communities around us

Seminar series, mentoring and continuing education programs

Employee engagement and staff surveys to ensure voices are heard

16

E

onent

@ 2026 Exponent. Inc. | Privileged & Confidential

17

Proven Financial Results

$700

$600

$500

$400

$300

$200

$100

$0

$70

$60

$50

$40

$30

$20

$10

$0

Revenue ($M)

$466M

$513M

$536M

$559M

$582 M

$400M

2020 2021 2022 2023 2024 2025

Dividends Paid ($M)

$54M

$58M

$49M

$40M

$43M

$62M

2020 2021 2022 2023 2024 2025

35%

30%

25%

20%

15%

10%

5%

0%

$140

$120

$100

$80

$60

$40

$20

$0

EBITDA Margin1,2 (%)

27.0%

27.7%

28.4%

27.6%

30.4% 29.6%

2020 2021 2022 2023 2024 2025

Free Cash Flow ($M)

$138M

$118M

$111M

$122M

$98M

$82M

2020 2021 2022 2023 2024 2025

1Refer to non-GAAP reconciliation on slide 25

2EBITDA Margin % = EBITDA/Revenues before Reimbursements

18

Capital Allocation

$350

$300

Cash and Short Term Investments ($M):

2020-2025

$297.7M

$258.9M

$242.5M

$221.9M

$187.2M

$161.5M

$331M

Repurchased Shares (or ~4.2M shares)

2020-2025

Cash Returned to Shareholders:

$306M

Dividend Payments

$250

$200

$150

$100

$50

$0

2020 2021 2022 2023 2024 2025

19

Key Metrics - Q1 2026

($ Millions, except where noted) 2025 2026 % Change

Revenues Before Reimbursements

$137.4

$151.8

10%

Revenues

145.5

166.3

14%

EBITDA1

$37.5

$43.1

15%

EBITDA Margin2 (%)

27.3%

28.4%

Net Income

26.7

29.6

11%

Earnings per share ($)

0.52

0.59

13%

Average diluted shares outstanding (Millions)

51.7

50.1

-3%

Billable hours

376,000

399,000

6%

Utilization, technical

75%

76%

Realized rate increase

4%

4%

Technical full time equivalent employees

966

1,013

5%

1Refer to non-GAAP reconciliation on slide 25

2EBITDA Margin % = EBITDA/Revenues before Reimbursements

20

Disclaimer

Exponent Inc. published this content on April 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 01, 2026 at 03:43 UTC.